​

GE HealthCare (GEHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GEHC Stock Forecast

GE HealthCare stock forecast is as follows: an average price target of $92.00 (represents a 16.59% upside from GEHC’s last price of $78.91) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.

GEHC Price Target

The average price target for GE HealthCare (GEHC) is $92.00 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $100.00 to $74.00. This represents a potential 16.59% upside from GEHC's last price of $78.91.

GEHC Analyst Ratings

Buy

According to 12 Wall Street analysts, GE HealthCare's rating consensus is 'Buy'. The analyst rating breakdown for GEHC stock is 0 'Strong Buy' (0.00%), 8 'Buy' (66.67%), 3 'Hold' (25.00%), 1 'Sell' (8.33%), and 0 'Strong Sell' (0.00%).

GE HealthCare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 15, 2024Jason BednarPiper Sandler$97.00$82.0818.18%22.92%
Sep 26, 2024Graham DoyleUBS$74.00$93.01-20.44%-6.22%
Sep 20, 2024Craig BijouBank of America Securities$97.00$90.627.04%22.92%
Sep 18, 2024Ryan ZimmermanBTIG$100.00$86.7915.22%26.73%
May 30, 2024David RomanGoldman Sachs$87.00$78.4510.90%10.25%
May 21, 2024Jason BednarPiper Sandler$92.00$81.5012.88%16.59%
May 01, 2024Anthony PetroneMizuho Securities$105.00$77.7435.07%33.06%
Apr 30, 2024Vijay KumarEvercore ISI$96.00$76.2425.92%21.66%
Apr 11, 2024Anthony PetroneMizuho Securities$110.00$85.3928.82%39.40%
Apr 01, 2024David ToungArgus Research$110.00$90.9121.00%39.40%
Feb 12, 2024Graham DoyleUBS$88.00$83.175.81%11.52%
Jun 27, 2023Patrick WoodMorgan Stanley$76.00$77.17-1.52%-3.69%
May 16, 2023Suraj KaliaOppenheimer$97.00$77.0025.97%22.92%

The latest GE HealthCare stock forecast, released on Nov 15, 2024 by Jason Bednar from Piper Sandler, set a price target of $97.00, which represents a 18.18% increase from the stock price at the time of the forecast ($82.08), and a 22.92% increase from GEHC last price ($78.91).

GE HealthCare Price Target by Period

1M3M12M
# Anlaysts-411
Avg Price Target-$92.00$96.00
Last Closing Price$78.91$78.91$78.91
Upside/Downside-100.00%16.59%21.66%

In the current month, the average price target of GE HealthCare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to GE HealthCare's last price of $78.91. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Nov 15, 2024Piper SandlerOverweightOverweightHold
Oct 01, 2024Evercore ISIOutperformOutperformHold
Sep 26, 2024UBSNeutralSellDowngrade
Sep 18, 2024BTIGBuyUpgrade
May 30, 2024Goldman SachsNeutralInitialise
May 21, 2024Piper SandlerOverweightOverweightHold
Apr 30, 2024Evercore ISIOutperformOutperformHold
Apr 03, 2024CitigroupBuyBuyHold
Apr 01, 2024Argus ResearchBuyBuyHold
Feb 12, 2024UBSSellNeutralUpgrade
Nov 27, 2023UBSSellDowngrade
Sep 19, 2023CitigroupBuyInitialise
Aug 16, 2023Wells FargoOverweightInitialise
Jun 27, 2023Morgan StanleyEqual-WeightInitialise
Feb 17, 2023Mizuho SecuritiesBuyInitialise
Jan 04, 2023Edward JonesHoldInitialise
Dec 15, 2022OppenheimerOutperformUpgrade

GE HealthCare's last stock rating was published by Piper Sandler on Nov 15, 2024. The company gave GEHC a "Overweight" rating, the same as its previous rate.

GE HealthCare Financial Forecast

GE HealthCare Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
Revenue---------$4.82B$4.82B$4.71B$4.94B
Avg Forecast$5.60B$5.05B$4.97B$4.77B$5.34B$4.87B$4.88B$4.80B$5.09B$4.80B$4.79B$4.63B$4.90B
High Forecast$5.65B$5.09B$5.01B$4.80B$5.36B$4.87B$4.88B$4.80B$5.20B$4.86B$4.83B$4.67B$4.94B
Low Forecast$5.55B$5.01B$4.93B$4.72B$5.32B$4.87B$4.88B$4.80B$5.03B$4.75B$4.75B$4.60B$4.86B
# Analysts4446942248544
Surprise %---------1.00%1.01%1.02%1.01%

GE HealthCare's average Quarter revenue forecast for Dec 23 based on 4 analysts is $5.09B, with a low forecast of $5.03B, and a high forecast of $5.20B. GEHC's average Quarter revenue forecast represents a 5.63% increase compared to the company's last Quarter revenue of $4.82B (Sep 23).

GE HealthCare EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts4446942248544
EBITDA---------$617.00M$570.00M$839.00M$777.00M
Avg Forecast$1.04B$933.63M$919.77M$881.92M$986.44M$900.11M$901.47M$887.73M$941.76M$888.29M$886.05M$856.78M$905.96M
High Forecast$1.04B$941.09M$927.12M$887.46M$990.14M$900.34M$901.47M$887.73M$962.11M$898.87M$893.13M$863.63M$913.20M
Low Forecast$1.03B$925.98M$912.23M$872.70M$982.75M$899.87M$901.47M$887.73M$930.66M$877.74M$878.79M$849.76M$898.54M
Surprise %---------0.69%0.64%0.98%0.86%

4 analysts predict GEHC's average Quarter EBITDA for Dec 23 to be $941.76M, with a high of $962.11M and a low of $930.66M. This is 52.63% upper than GE HealthCare's previous annual EBITDA (Sep 23) of $617.00M.

GE HealthCare Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts4446942248544
Net Income---------$886.00M$707.00M$383.00M$554.00M
Avg Forecast$627.27M$543.91M$501.34M$450.23M$579.55M$483.08M$448.38M$416.20M$491.36M$411.75M$398.96M$363.76M$896.85M
High Forecast$633.78M$549.56M$506.55M$459.42M$597.95M$483.18M$448.41M$416.25M$495.95M$420.89M$403.10M$367.54M$906.16M
Low Forecast$620.59M$538.12M$496.00M$445.63M$574.95M$482.97M$448.35M$416.14M$482.17M$398.02M$394.71M$359.88M$887.30M
Surprise %---------2.15%1.77%1.05%0.62%

GE HealthCare's average Quarter net income forecast for Dec 23 is $491.36M, with a range of $482.17M to $495.95M. GEHC's average Quarter net income forecast represents a -44.54% decrease compared to the company's last Quarter net income of $886.00M (Sep 23).

GE HealthCare SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts4446942248544
SG&A---------$996.00M$1.07B$1.06B$884.00M
Avg Forecast$1.15B$1.03B$1.02B$976.97M$1.09B$997.12M$998.62M$983.40M$1.04B$984.02M$981.54M$949.12M$1.00B
High Forecast$1.16B$1.04B$1.03B$983.10M$1.10B$997.38M$998.62M$983.40M$1.07B$995.74M$989.38M$956.70M$1.01B
Low Forecast$1.14B$1.03B$1.01B$966.75M$1.09B$996.86M$998.62M$983.40M$1.03B$972.34M$973.50M$941.34M$995.38M
Surprise %---------1.01%1.09%1.12%0.88%

GE HealthCare's average Quarter SG&A projection for Dec 23 is $1.04B, based on 4 Wall Street analysts, with a range of $1.03B to $1.07B. The forecast indicates a 4.74% rise compared to GEHC last annual SG&A of $996.00M (Sep 23).

GE HealthCare EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22
# Analysts4446942248544
EPS---------$1.95$1.55$0.84$1.31
Avg Forecast$1.37$1.18$1.09$0.98$1.26$1.05$0.98$0.91$1.07$0.90$0.87$0.79$1.95
High Forecast$1.38$1.20$1.10$1.00$1.30$1.05$0.98$0.91$1.08$0.92$0.88$0.80$1.97
Low Forecast$1.35$1.17$1.08$0.97$1.25$1.05$0.98$0.91$1.05$0.87$0.86$0.78$1.93
Surprise %---------2.17%1.78%1.06%0.67%

According to 4 Wall Street analysts, GE HealthCare's projected average Quarter EPS for Dec 23 is $1.07, with a low estimate of $1.05 and a high estimate of $1.08. This represents a -45.10% decrease compared to GEHC previous annual EPS of $1.95 (Sep 23).

GE HealthCare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AMWLAmerican Well$8.45$148.131653.02%Hold
GDRXGoodRx$4.46$14.57226.68%Buy
TXG10x Genomics$14.72$31.75115.69%Hold
PGNYProgyny$14.74$22.6753.80%Hold
SDGRSchrödinger$21.36$28.5033.43%Buy
GEHCGE HealthCare$79.25$92.0016.09%Buy
TDOCTeladoc Health$10.07$11.009.24%Buy
VEEVVeeva Systems$226.41$235.504.01%Buy
DOCSDoximity$52.70$53.381.29%Buy

GEHC Forecast FAQ

Is GE HealthCare a good buy?

Yes, according to 12 Wall Street analysts, GE HealthCare (GEHC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 66.67% of GEHC's total ratings.

What is GEHC's price target?

GE HealthCare (GEHC) average price target is $92 with a range of $74 to $100, implying a 16.59% from its last price of $78.91. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will GE HealthCare stock go up soon?

According to Wall Street analysts' prediction for GEHC stock, the company can go up by 16.59% (from the last price of $78.91 to the average price target of $92), up by 26.73% based on the highest stock price target, and down by -6.22% based on the lowest stock price target.

Can GE HealthCare stock reach $120?

GEHC's average twelve months analyst stock price target of $92 does not support the claim that GE HealthCare can reach $120 in the near future.

What are GE HealthCare's analysts' financial forecasts?

GE HealthCare's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $19.88B (high $19.9B, low $19.86B), average EBITDA is $3.68B (high $3.68B, low $3.67B), average net income is $1.93B (high $1.95B, low $1.92B), average SG&A $4.07B (high $4.08B, low $4.07B), and average EPS is $4.2 (high $4.24, low $4.19). GEHC's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $20.39B (high $20.55B, low $20.22B), average EBITDA is $3.77B (high $3.8B, low $3.74B), average net income is $2.12B (high $2.15B, low $2.1B), average SG&A $4.18B (high $4.21B, low $4.14B), and average EPS is $4.62 (high $4.68, low $4.58).

Did the GEHC's actual financial results beat the analysts' financial forecasts?

Based on GE HealthCare's last annual report (Dec 2023), the company's revenue was $19.55B, beating the average analysts forecast of $19.32B by 1.18%. Apple's EBITDA was $2.44B, missing the average prediction of $3.57B by -31.85%. The company's net income was $3.1B, beating the average estimation of $1.67B by 86.33%. Apple's SG&A was $4.28B, beating the average forecast of $3.96B by 8.19%. Lastly, the company's EPS was $6.82, beating the average prediction of $3.63 by 87.92%. In terms of the last quarterly report (Sep 2023), GE HealthCare's revenue was $4.82B, beating the average analysts' forecast of $4.8B by 0.37%. The company's EBITDA was $617M, missing the average prediction of $888.29M by -30.54%. GE HealthCare's net income was $886M, beating the average estimation of $411.75M by 115.18%. The company's SG&A was $996M, beating the average forecast of $984.02M by 1.22%. Lastly, the company's EPS was $1.95, beating the average prediction of $0.897 by 117.38%